Barbara Zdrazil

Dr. Barbara Zdrazil

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BZBarbara Zdrazil
Barbara Zdrazil
EFEloy Felix
Eloy Felix
FHFiona Hunter
Fiona Hunter
EMEmma J Manners
Emma J Manners
JBJames Blackshaw
James Blackshaw
ALAndrew R Leach
Andrew R Leach
ChEMBL (https://www.ebi.ac.uk/chembl/) is a manually curated, high-quality, large-scale, open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like properties, previously described in the 2012, 2014, 2017 and 2019 Nucleic Acids Research Database Issues. Since its introduction in 2009, ChEMBL’s content has changed dramatically in size and diversity of data types. Through incorporation of multiple new datasets from depositors since the 2019 update, ChEMBL now contains slightly more bioactivity data from deposited data vs data extracted from literature. In collaboration with the EUbOPEN consortium, chemical probe data is now regularly deposited into ChEMBL. Release 27 made curated data available for compounds screened for potential anti-SARS-CoV-2 activity from several large-scale drug repurposing screens. In addition, new patent bioactivity data have been added to the latest ChEMBL releases, and various new features have been incorporated, including a Natural Product likeness score, updated flags for Natural Products, a new flag for Chemical Probes, and the initial annotation of the action type for ∼270 000 bioactivity measurements.

11 September 2023 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
MMMichael Mullowney
Michael Mullowney
KDKatherine Duncan
Katherine Duncan
SESomayah Elsayed
Somayah Elsayed
NGNeha Garg
Neha Garg
Justin Van der HooftJustin Van der Hooft
Justin Van der Hooft
MMMarnix H. Medema
Marnix H. Medema

19 October 2017 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
MLMarcel Leist
Marcel Leist
AGAhmed Ghallab
Ahmed Ghallab
RGRabea Graepel
Rabea Graepel
RMRosemarie Marchan
Rosemarie Marchan
RHReham Hassan
Reham Hassan
Jan G HengstlerJan G Hengstler
Jan G Hengstler

1 April 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Sonja SucicSonja Sucic
Sonja Sucic
SDStefan Dallinger
Stefan Dallinger
BZBarbara Zdrazil
Barbara Zdrazil
RWRené Weissensteiner
René Weissensteiner
TJTrine N. Jørgensen
Trine N. Jørgensen
HSHarald H. Sitte
Harald H. Sitte
The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft. In addition, it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux). We explored the functional importance of the N terminus in mediating the action of amphetamines by focusing initially on the highly conserved threonine residue at position 81, a candidate site for phosphorylation by protein kinase C. Molecular dynamics simulations of the wild type SERT, compared with its mutations SERTT81A and SERTT81D, suggested structural changes in the inner vestibule indicative of an opening of the inner vestibule. Predictions from this model (e.g. the preferential accumulation of SERTT81A in the inward conformation, its reduced turnover number, and a larger distance between its N and C termini) were verified. Most importantly, SERTT81A (and the homologous mutations in noradrenaline and dopamine) failed to support amphetamine-induced efflux, and this was not remedied by aspartate at this position. Amphetamine-induced currents through SERTT81A were comparable with those through the wild type transporter. Both abundant Na+ entry and accumulation of SERTT81A in the inward facing conformation ought to favor amphetamine-induced efflux. Thus, we surmised that the N terminus must play a direct role in driving the transporter into a state that supports amphetamine-induced efflux. This hypothesis was verified by truncating the first 64 amino acids and by tethering the N terminus to an additional transmembrane helix. Either modification abolished amphetamine-induced efflux. We therefore conclude that the N terminus of monoamine transporters acts as a lever that sustains reverse transport.

10 March 2025 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
BZBarbara Zdrazil
Barbara Zdrazil
In October 2024 we celebrated the 15th anniversary of the first launch of ChEMBL, Europe’s most impactful, open-access drug discovery database, hosted by EMBL’s European Bioinformatics Institute (EMBL-EBI). This is a good moment to reflect on ChEMBL’s history, the role that ChEMBL plays in Cheminformatics and Drug Discovery as well as innovations accelerated using data extracted from it. The review closes by discussing current challenges and possible directions that need to be taken to guarantee that ChEMBL continues to be the pioneering resource for highly curated, open bioactivity data on the European continent and beyond.

13 December 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BZBarbara Zdrazil
Barbara Zdrazil
RGRajarshi Guha
Rajarshi Guha